[图书][B] Comparative analysis of a two-dimensional and three-dimensional model of BT-20 triple negative breast carcinoma cells in response to an antiproliferative …

J Wang - 2018 - search.proquest.com
Triple-negative breast cancer (TNBC) lacks the expression of estrogen receptor-alpha,
progesterone receptor and human epidermal growth factor receptor 2 (HER2). The lack of …
相关文章

Comparative analysis of a two-dimensional and three dimensional model of BT-20 triple-negative breast carcinoma cells in response to an antiproliferative agent

J Wang, DA Duncan, I Van Den Bout, W Cordier - academia.edu
Background Triple-negative breast cancer lacks oestrogen, progesterone and human
epidermal growth factor-receptor-2 receptors, thus no specific target is available for …

Comparative analysis of a two-dimensional and three dimensional model of BT-20 triple-negative breast carcinoma cells in response to an antiproliferative agent

W Jie, AD Duncan, CW Van Den Bout Iman - 日本薬理学会年会要旨集, 2018 - cir.nii.ac.jp
抄録< p> Background</p>< p> Triple-negative breast cancer lacks oestrogen, progesterone
and human epidermal growth factor-receptor-2 receptors, thus no specific target is available …

Comparative analysis of a two-dimensional and three-dimensional model of BT-20 triple negative breast carcinoma cells in response to an antiproliferative agent

J Wang - 2018 - repository.up.ac.za
Triple-negative breast cancer (TNBC) lacks the expression of estrogen receptor-alpha,
progesterone receptor and human epidermal growth factor receptor 2 (HER2). The lack of …
[HTML] jst.go.jp

[HTML][HTML] Comparative analysis of a two-dimensional and three dimensional model of BT-20 triple-negative breast carcinoma cells in response to an antiproliferative …

J Wang, DA Duncan, I Van Den Bout… - Proceedings for Annual …, 2018 - jstage.jst.go.jp
Background Triple-negative breast cancer lacks oestrogen, progesterone and human
epidermal growth factor-receptor-2 receptors, thus no specific target is available for …